HLB Life Science Co. on Thursday announced that it will sell new shares to raise 148.5 billion won (US$112.3 million). The proceeds from the stock sale will be used mainly to pay off its debts.According to a regulatory filing, the company will issue some 11 million common shares at a price of 13,630 won per share. The stocks will be sold to the firm's shareholders.Source: Yonhap News Agency
Africa’s Nuclear Power Ambitions Face Major Challenges
March 29, 2026
Somalia and Saudi Arabia Ink Military Deal Amid Regional Tensions
February 16, 2026